Press release
Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics - Pipeline Analysis | Zymenex, BioXcel Corporation
Download the sample report @ https://www.pharmaproff.com/request-sample/1133
There is no cure for Krabbe disease, however, hematopoietic stem cell transplant (HSCT) has demonstrated some positive effects on the disease. Moreover, patient’s quality of life can be improved by anticonvulsant medication to stop seizures, muscle relaxer drugs, physical therapy to help slow deterioration of muscles and occupational therapy.
Get the detailed analysis @ https://www.pharmaproff.com/report/globoid-cell-leukodystrophy-therapeutics-pipeline-analysis
MediciNova Inc. is developing MN-166 (ibudilast) as a novel, orally bioavailable small molecule compound which exerts its effects through several mechanisms to produce its anti-fibrotic and anti-inflammatory activity for the treatment of Krabbe disease. BioXcel Corporation, and Zymenex A/S are some other key players involved in the development of therapeutics for Krabbe disease.
Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1133
• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Globoid Cell Leukodystrophy (Krabbe Disease) Therapeutics - Pipeline Analysis | Zymenex, BioXcel Corporation here
News-ID: 1727287 • Views: …
More Releases for Krabbe
Krabbe Disease Market to Witness Promising Upswing by 2034, DelveInsight Forecas …
DelveInsight's "Krabbe Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Krabbe Disease, historical and forecasted epidemiology as well as the Krabbe Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Krabbe Disease, offering comprehensive insights into the Krabbe Disease revenue trends, prevalence, and treatment landscape. The…
Krabbe Disease Treatment Market Size Expected to Surge to USD 8.69 Billion by 20 …
The global Krabbe Disease Treatment Market size is projected to experience substantial growth, reaching an estimated market size of approximately USD 8.69 billion by 2032, up from USD 4.07 billion in 2023. This represents a robust compound annual growth rate (CAGR) of 8.79% over the study period from 2024 to 2032, according to Value Market Research. The anticipated growth is driven by increasing awareness of Krabbe disease, advancements in treatment…
Krabbe Disease Treatment Market Shows Booming Growth with Surprising Transition …
The "Global Krabbe Disease Treatment" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Global Krabbe Disease Treatment provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures…
Global Krabbe Disease Treatment Market - Opportunities & Forecasts, 2020-2029
The research report from Dhirtek Business Research and Consulting is a thorough examination of the global krabbe disease treatment market. Subject matter experts and a team of highly trained researchers have worked tirelessly to compile an original research report on the global krabbe disease treatment market. Analysts have researched the various items on the market and provided unbiased opinions on the variables that are expected to drive and constrain the…
Krabbe Disease Drugs Market Global Strategies and Insight driven transformation …
Krabbe Disease Drugs Market research report is a professional and an in-depth study available on the market size, share, growth, trends, in addition to industry evaluation. Krabbe Disease Drugs Market report provides a thorough analysis and competitive analysis by region and added main information like a manufacturing process, raw material and equipment suppliers, various manufacturing associated costs, revenue, historical and futuristic cost, demand and supply data.
Moreover, the study presents a…
Krabbe Disease Treatment Market - Global Industry Trends,Size, Applications and …
Krabbe disease is a rare inherited genetic disorder that affects the nervous system. It is usually caused by the deficiency of the galactosylceramidase (GLC) enzyme. The disease is inherited in an autosomal recessive pattern.
global krabbe disease treatment market to grow at a CAGR of 7.24% during the period 2018-2022.
Get Sample@ https://www.researchbeam.com/global-krabbe-disease-treatment-2018-2022-market/request-sample
Covered in this report
The report covers the present scenario and the growth prospects of the global krabbe disease…
